KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients (Q27653496)

2

Joe C

Wu

1 reference

20 October 2023

James Christensen

3

James

Christensen

1 reference

20 October 2023

Gayatri D Deshmukh

4

Gayatri D

Deshmukh

1 reference

20 October 2023

Wade Diehl

5

Wade

Diehl

1 reference

20 October 2023

Jonathan P DiNitto

6

Jonathan P

DiNitto

1 reference

20 October 2023

Jessie M English

7

Jessie M

English

1 reference

20 October 2023

Michael J Greig

8

Michael J

Greig

1 reference

20 October 2023

You-Ai He

9

You-Ai

He

1 reference

20 October 2023

Suzanne L Jacques

10

Suzanne L

Jacques

1 reference

20 October 2023

Elizabeth A Lunney

11

Elizabeth A

Lunney

1 reference

20 October 2023

Michele McTigue

12

Michele

McTigue

1 reference

20 October 2023

David Molina

13

David

Molina

1 reference

20 October 2023

Terri Quenzer

14

Terri

Quenzer

1 reference

20 October 2023

Peter A Wells

15

Peter A

Wells

1 reference

20 October 2023

Xiu Yu

16

Xiu

Yu

1 reference

20 October 2023

Yan Zhang

17

Yan

Zhang

1 reference

20 October 2023

Aihua Zou

18

Aihua

Zou

1 reference

20 October 2023

Mark R Emmett

19

Mark R

Emmett

1 reference

20 October 2023

Alan G Marshall

20

Alan G

Marshall

1 reference

20 October 2023

Hui-Min Zhang

21

Hui-Min

Proceedings of the National Academy of Sciences of the United States of America

Zhang

1 reference

20 October 2023

language of work or name

English

0 references

publication date

3 February 2009

0 references

published in

0 references

volume

106

0 references

page(s)

1542-7

0 references

issue

5

0 references

cites work

The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635778

Crystal structure of the T315I mutant of AbI kinase

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635778

Structure of a c-kit product complex reveals the basis for kinase transactivation

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635778

Structural mechanism for STI-571 inhibition of abelson tyrosine kinase

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635778

Molecular correlates of imatinib resistance in gastrointestinal stromal tumors.

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635778

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635778

Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635778

A potent fluorescent ATP-like inhibitor of cAMP-dependent protein kinase

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635778

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635778

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635778

Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635778

Enhanced digestion efficiency, peptide ionization efficiency, and sequence resolution for protein hydrogen/deuterium exchange monitored by Fourier transform ion cyclotron resonance mass spectrometry

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635778

Fast reversed-phase liquid chromatography to reduce back exchange and increase throughput in H/D exchange monitored by FT-ICR mass spectrometry

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635778

Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635778

Biology of gastrointestinal stromal tumors.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635778

Human recombinant [C22A] FK506-binding protein amide hydrogen exchange rates from mass spectrometry match and extend those from NMR

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635778

Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation

29 September 2017

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0812413106

Structural basis for the autoinhibition and STI-571 inhibition of c-Kit tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0812413106

The T790M "gatekeeper" mutation in EGFR mediates resistance to low concentrations of an irreversible EGFR inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0812413106

Analysis of KIT mutations in sporadic and familial gastrointestinal stromal tumors: therapeutic implications through protein modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0812413106

Micro-electrospray mass spectrometry: Ultra-high-sensitivity analysis of peptides and proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0812413106

In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2635778

High-performance mass spectrometry: Fourier transform ion cyclotron resonance at 14.5 Tesla

27 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19164557

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1073/PNAS.0812413106

1 reference

3145525

ADS bibcode

2009PNAS..106.1542G

0 references

3145525

1 reference

1 reference

1 reference